Xiaobu Ye

Medicine · Health Sciences

47h-index10.6kcitations328works2.12yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Glioma Diagnosis and Treatment(183), Cancer, Hypoxia, and Metabolism(50), Brain Metastases and Treatment(42), Radiopharmaceutical Chemistry and Applications(41), Cancer Immunotherapy and Biomarkers(35)

Publications328 total

Erratum: Efficacy and Biomarker Study of Bevacizumab for Hearing Loss Resulting From Neurofibromatosis Type 2–Associated Vestibular Schwannomas
Journal of Clinical Oncology·2026
CTIM-22. WINDOW OF OPPORTUNITY STUDY OF NIVOLUMAB AND IPILIMUMAB IN PEOPLE WITH NEUROFIBROMATOSIS TYPE 1 AND NEWLY DIAGNOSED MALIGNANT AND PRE-MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
Neuro-Oncology·2025Open Access
Phase I/II and window-of-opportunity study of pamiparib and metronomic temozolomide for recurrent isocitrate dehydrogenase mutant gliomas
Neuro-Oncology·2025
NCTQ-07 IMPACT OF SEX ON BRAIN METASTASIS PREVALENCE AND SURVIVAL OUTCOMES IN MELANOMA: A RETROSPECTIVE ANALYSIS OF THE TRINETX ONCOLOGY DATABASE
Neuro-Oncology Advances·2025Open Access
NCTQ-06 PREVALENCE OF MELANOMA BRAIN METASTASES AND PATIENT SURVIVAL OUTCOMES: A POPULATION-BASED STUDY FROM 2014-2024
Neuro-Oncology Advances·2025Open Access
Prevalence, therapeutic approaches, and survival rates of brain metastases in non-small cell lung cancer: a multi-institutional claims-based study from 2014 to 2024
Journal of Neuro-Oncology·2025· 2 cited
Data from Phase I Study of Adavosertib with Radiotherapy and Temozolomide in Newly Diagnosed Glioblastoma and Intratumoral Drug Levels in Recurrent Glioblastoma
2025Open Access
Supplementary Table 2 from Phase I Study of Adavosertib with Radiotherapy and Temozolomide in Newly Diagnosed Glioblastoma and Intratumoral Drug Levels in Recurrent Glioblastoma
2025Open Access
Supplementary Figure 1 from Phase I Study of Adavosertib with Radiotherapy and Temozolomide in Newly Diagnosed Glioblastoma and Intratumoral Drug Levels in Recurrent Glioblastoma
2025Open Access
Supplementary Table 1 from Phase I Study of Adavosertib with Radiotherapy and Temozolomide in Newly Diagnosed Glioblastoma and Intratumoral Drug Levels in Recurrent Glioblastoma
2025Open Access
A multi-institutional phase 1 clinical trial exploring upfront multimodal standard of care and combined immunotherapies for newly diagnosed glioblastoma
Neuro-Oncology·2025· 4 citedOpen Access
A window-of-opportunity trial reveals mechanisms of response and resistance to navtemadlin in patients with recurrent glioblastoma
Science Translational Medicine·2025· 9 cited
Phase I Study of Adavosertib with Radiotherapy and Temozolomide in Newly Diagnosed Glioblastoma and Intratumoral Drug Levels in Recurrent Glioblastoma
Clinical Cancer Research·2025· 4 citedOpen Access
Phase I study of NT-I7, a long-acting interleukin-7, in severe treatment-related lymphopenia following standard radiation and temozolomide for high-grade glioma
Neuro-Oncology Advances·2025· 2 citedOpen Access
Glucagon-Like Peptide-1 Receptor Agonists and Primary Malignant Brain Tumor Risk in Type 2 Diabetes
Brain and Spine·2025Open Access
Assessing the dose of regadenoson required to transiently alter blood-brain barrier integrity in patients with infiltrating gliomas
Neuro-Oncology Advances·2025Open Access
Author Correction: Intravenous and intracranial GD2-CAR T cells for H3K27M+ diffuse midline gliomas
Nature·2024· 12 citedOpen Access
Intravenous and intracranial GD2-CAR T cells for H3K27M+ diffuse midline gliomas
Nature·2024· 126 citedOpen Access
EPID-29. EPIDEMIOLOGICAL CHARACTERIZATION OF BRAIN METASTASES IN MELANOMA: A LARGE POPULATION BASED-STUDY FROM 2014-2024
Neuro-Oncology·2024· 1 citedOpen Access
Prevalence, treatment patterns, and survival of patients with brain metastases from small cell lung cancer: A retrospective study using the TriNetX Oncology Database
Neuro-Oncology Practice·2024· 2 citedOpen Access
page 1 of 17Next →

Frequent Co-authors

Stuart A. Grossman(23), Michael Lim(12), Serena Desideri(9), Henry Brem(9), Dimitrios Mathios(7), Drew M. Pardoll(7), Joy Fisher(6), Matthias Holdhoff(6), Debebe Theodros(6), Phuoc T. Tran(6), Jeffrey G. Supko(5), Kaisorn L. Chaichana(5), Jaishri O. Blakeley(5), Alfredo Quiñones‐Hinojosa(5), Eileen Kim(5), Christopher M. Jackson(5), Tomás Garzón-Muvdi(5), Betty Tyler(5), Lawrence Kleinberg(5), Kristin J. Redmond(5)